Trial Profile
Safety of infliximab in patients with inflammatory bowel disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Inflammatory bowel diseases
- Focus Adverse reactions
- 15 Dec 2016 New trial record
- 19 Oct 2016 Results presented at the 24th United European Gastroenterology Week